NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES VANCOUVER, British Columbia--(BUSINESS WIRE)--Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly" or the “Company”) announces that it intends to settle outstanding c
Precision imaging for precision medicine THUNDER BAY & TORONTO, Ontario--(BUSINESS WIRE)--Radialis Medical today announced that it has submitted a U.S. Food & Drug Administration (FDA) 510(k) premarket notification for the Radialis PET Camera, an org
Flora signs Letter of Intent with an international importer and distributor based in Panama to provide cannabinoid containing food and beverages through its Kasa Wholefoods division, and finished cannabis derivative products for medical cannabis patient
OTTAWA, Ontario--(BUSINESS WIRE)--$BWXT--BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Medical Ltd. subsidiary (BWXT Medical) has entered into an agreement with Bayer AG (Bayer) to develop Actinium-225 (Ac-225) supply and further partn
Confirmed objective response rate (cORR) of 75% overall and 93% for the proposed Phase 3 regimen (zanidatamab + CAPOX/FP) Median duration of response (mDOR) of 16.4 months and median progression free survival (mPFS) of 12 months Data support zanidat
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the senior management team will present at the following upcoming virtual investor conferences: Oppenheimer Fall
Partnership combines AbCellera’s AI-powered antibody discovery platform with Moderna’s mRNA technology platform to accelerate the development of mRNA-encoded antibody therapeutics across multiple indications VANCOUVER, British Columbia--(BUSINESS WIR
VANCOUVER, British Columbia--(BUSINESS WIRE)--$CALM #CANADIANSECURITIESEXCHANGE--REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (CSNX: CALM.CN) is pleased to formally announce the opening of its fifth psychedeli
Pre-clinical testing has demonstrated manufacturing stability and statistically significant antibody production BURLINGTON, Ontario--(BUSINESS WIRE)--Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) and McMaster Universit
CHICAGO--(BUSINESS WIRE)--Nucleai, a leader in AI-powered spatial biology, and Jefferson Health, a leading cancer center, announce that they have entered into a strategic collaboration to discover spatial immunotherapy biomarkers, leveraging Nucleai’s A
As part of the Global Biotech Week 2023 celebrations, BAM is not only celebrating the success stories within Manitoba's thriving $9.9 billion biotech industry but also taking a significant step towards securing its future.
Newly launched MY Sleep Scoring API provides free access to leading sleep analysis metric, accelerating research into the clinical management of disrupted sleep.
Provinces and territories will have access to updated COVID-19 vaccines for their respective fall vaccination campaigns
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.